Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026
2027
2028
2029
2030
Trend
ROE
1.18%
1.15%
1.36%
1.45%
1.59%
1.67%
ROA
1.05%
1.02%
1.21%
1.28%
1.39%
1.45%
Gross Margin
73.81%
73.81%
73.81%
73.81%
73.81%
73.81%
Sector average
16.85%
17.71%
17.71%
17.71%
17.71%
17.71%
Net Margin
Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for Xvivo Perfusion AB (publ)? It covers the balance sheet, income statement and Equlion model projections.
3.1%
2.87%
3.06%
2.86%
2.84%
2.84%
Total Assets
SEK 2,374,112.00K
SEK 2,405,236.17K
SEK 2,452,445.52K
SEK 2,509,568.04K
SEK 2,566,993.55K
SEK 2,618,383.67K
Sector average
SEK 2,857,190.78K
SEK 2,900,240.60K
SEK 3,045,009.79K
SEK 3,280,286.42K
SEK 3,536,407.14K
SEK 3,762,908.71K
Net Income
SEK 25,163.00K
SEK 24,465.09K
SEK 29,331.72K
SEK 31,719.44K
SEK 35,336.28K
SEK 37,583.79K
Sector average
-SEK 2,851.32K
-SEK 22,027.28K
-SEK 904.69K
-SEK 7,253.84K
-SEK 3,858.45K
-SEK 1,547.00K
Valuation
SEK 5,877,801.10K
SEK 6,002,842.94K
SEK 6,120,548.35K
SEK 6,238,644.71K
SEK 6,353,712.44K
SEK 6,470,160.50K
Sector average
SEK 3,960,502.41K
SEK 5,151,301.60K
SEK 5,189,236.02K
SEK 5,317,343.69K
SEK 5,514,329.75K
SEK 5,636,782.17K
Stock Price
SEK 186.60
SEK 190.57
SEK 194.31
SEK 198.06
SEK 201.71
SEK 205.41
Sector average
SEK 57.22
SEK 48.04
SEK 48.69
SEK 50.45
SEK 52.13
SEK 53.41
Xvivo Perfusion AB (publ) (XVIVO.ST) Financial Forecast | Equlion
